Pharmaceutical manufacturers of Tretinoin

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 80 billion doses of nearly 8,000 products annually. Its rapidly growing expert workforce exceeds 18,000, including more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, Catalent, Inc. (NYSE:CTLT), is in S&P 500® company, and generated nearly $5 billion in revenue in its 2022 fiscal year.

OLON Group is a prominent worldwide firm specializing in the creation and manufacture of active pharmaceutical ingredients for CDMO and Generics. It serves as a dependable and preferred partner for the pharmaceutical, biotech, and specialty ingredients sectors. With a 2021 turnover of 580 million dollars, OLON provides 300 APIs for the Generic market. The company benefits from a workforce of 2,300 employees, including a highly skilled R&D team of over 300 individuals. This enables OLON to offer comprehensive integrated packages and services to facilitate the full development of APIs, leveraging extensive expertise in both Chemical and Biological processes, all within a full cGMP and regulatory framework. OLON holds approximately 160 active US DMFs and 79 granted CoS. OLON's headquarters is located in Rodano, near Milan, Italy, and it operates 11 manufacturing facilities - 8 in Italy, 1 in Spain, 1 in the USA, and 1 in India. These facilities are designed in accordance with the most stringent international standards. Additionally, OLON has 3 branch offices in Hamburg (Germany), Florham Park, NJ (USA), and Shanghai (China).

Biophore, founded in 2007, has established itself as a dependable partner in the development and production of unique and intricate pharmaceutical products. With 4 USFDA and EU-certified API manufacturing facilities, a specialized intermediate facility, and a research and development laboratory accommodating 400 scientists, Biophore has positioned itself as a worldwide leader among API companies. It consistently ranks among the top 10 US DMF submitters and has acquired over 150 patents globally in process and polymorph areas. Biophore's facilities have an impressive history of successful inspections by regulatory authorities such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

We help our partners solve society’s greatest challenges with technologies like molecular recycling, which takes plastic that would otherwise end up in landfills or incinerators and breaks it down to its original building blocks so it can be used over and over again. Our success has always been built around customer collaboration, and we’ll continue to work together to develop sustainable materials that open up countless possibilities for the future.

The Saraf group of enterprises was established by the forward-thinking Shri Mahavir G. Saraf in 1952. Sarex Overseas represents a segment of the Saraf group of corporations, and its primary operations center on being a prominent producer of Fine Chemicals and API Intermediates within India. The corporate headquarters of Sarex Overseas is situated in Mumbai, while its manufacturing facility is located in MIDC, Tarapur, which is approximately 100 kilometers from Mumbai in India. Sarex, which was founded in 2002, has garnered a reputation as a reputable Exporter, Manufacturer, and Supplier in India, focusing on producing Active Pharmaceutical Ingredients (API), Bulk Drug Intermediates, and Veterinary Medicines, including IVERMECTIN EP, among others. The organization's adept team of professionals, under expert guidance, processes all products, and the finished range undergoes thorough scrutiny by quality analysts based on various parameters such as composition, pH value, viscosity, and packaging. The company utilizes top-notch materials for packaging. Sarex specializes in the production of high-quality organic fine chemicals for the pharmaceutical and electronics industries, with a focus on Fridel craft, halogenation, nitration, oxidation, and high-pressure reactions. Notably, Sarex excels in process development and customer synthesis, operates pilot plants, and engages in bulk production of heterocycles like Tetrazoles, Triazines, and Quinazolines, among others. Its multipurpose plants include Glass-lined reactors, Stainless steel reactors, high-pressure reactors, and high vacuum distillation units, all supported by QA, QC, and R&D. The company serves as a supplier to numerous catalogue companies for small and bulk quantities and also provides toll manufacturing for large multinational companies.

KAWAKEN is not just involved in the provision of its products, but also in precise and timely research, innovation, manufacturing, and marketing of products to meet the diverse demands of our clients through close collaboration between the Household Chemicals Department and the Fine Chemicals Department within our factories' two core divisions.